Severe Hypertriglyceridemia Presenting as Superior Sagittal Sinus Thrombosis
Abstract
We report a case of a 38-year-old Indian male who presented with severe throbbing headache spreading diffusely from occipital to nuchal regions. He was detected to have superior cerebral (sagittal) venous sinus thrombosis (CVST) with severe hypertriglyceridemia without any coagulation abnormalities or autoimmune disease. Our case highlights the need for clinicians to consider CVST among patients with uncontrolled hypertriglyceridemia. New prognostic measures may become necessary having an implication on the risk of recurrence and duration of anticoagulant therapy in CVST.
Downloads
References
Stam J. Thrombosis of the cerebral veins and sinuses. New Engl J Med.2005; 352:1791-98. http://dx.doi.org/10.1056/NEJMra042354.
Bousser MG, Chiras J, Bories J, et al. Cerebral venous thrombosis – a review of 38 cases. Stroke.1985; 16:199-213.http://dx.doi.org/10.1161/01.STR.16.2.199.
Allroggen H, Abbott RJ. Cerebral venous sinus thrombosis. Postgrad Med J. 2000; 76:12-15.
http://dx.doi.org/10.1136/pmj.76.891.12.
Kamphuisen PW, Eikenboom JC, vos HL, et al. Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions.ThrombHaemost. 1999; 81(5):680-683.
T-Y. Wang, J Yen, G-Y Hung, M-Y Hsieh, R-B Tang. A rare complication in a child undergoing chemotherapy for acute lymphoblastic leukemia: Superior sagittal sinus thrombosis. Journal of the Chinese Medical Association. 2011; 74:183-187. http://dx.doi.org/10.1016/j.jcma.2011.01.041.
Doggen CJM, Smith NL, Lemaitre RN, Heckbert SR, Rosendaal FR, Psaty BM. Serum lipid levels and the risk of venous thrombosis. Arterioscler Thromb Vasc Biol. 2004;24:1970 –1975. http://dx.doi.org/10.1161/01.ATV.0000143134.87051.46.
Candelaria GTB, Belangero VMS. "Predisposing factors for deep venous thrombosis in children and adolescents with nephrotic syndrome," ISRN Vascular Medicine. 2011; 1-5. http://dx.doi.org/10.5402/2011/827483.
Saxena R, Batra V, Singh ND, "Prothrombotic factors in nephrotic syndrome." Indian Journal of Pathology and Microbiology. 2000; 43(3)319–323.
García-Raso A, Santos Montero AB, Ene GS, Llamas Sillero P. Cardiovascular risk factors and venous thromboembolism: Is there a connection? J Hematol Transfus. 2013; 1(2): 1009.
Ciccone A, Canhão P, Falcão F, et al. Thrombolysis for cerebral vein and dural sinus thrombosis. Cochrane Database Syst Rev. 2004; (1):CD003693.
de Bruijn SFTM, Stam J, for the Cerebral Venous Thrombosis Study Group. Randomised, placebo-controlled trial of anticoagulation treatment with low-molecular-weight heparin for cerebral sinus
thrombosis. Stroke. 1999; 30: 484–488.
http://dx.doi.org/10.1161/01.STR.30.3.484.
van Nuenen BFL, Munneke M, Bloem BR. Cerebral venous sinus thrombosis: Prevention of recurrent thromboembolism. Stroke. 2005;
: 1822. http://dx.doi.org/10.1161/01.STR.0000176582.17934.82.
Mertens I, Verrijken A. Michiels JJ, et al. Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome. International Journal of Obesity. 2006; 30: 1308–1314.
Published
How to Cite
Issue
Section
License
Journal of the ASEAN Federation of Endocrine Societies is licensed under a Creative Commons Attribution-NonCommercial 4.0 International. (full license at this link: http://creativecommons.org/licenses/by-nc/3.0/legalcode).
To obtain permission to translate/reproduce or download articles or use images FOR COMMERCIAL REUSE/BUSINESS PURPOSES from the Journal of the ASEAN Federation of Endocrine Societies, kindly fill in the Permission Request for Use of Copyrighted Material and return as PDF file to jafes@asia.com or jafes.editor@gmail.com.
A written agreement shall be emailed to the requester should permission be granted.
